Aneesh Singhal
Vice Chair, Department of Neurology · Mass General Brigham
Credentials: · · · · · ·
History
- Present
Department of Neurology · Mass General Brigham
- Present
MGH Comprehensive Stroke Center · Mass General Brigham
- Present
Mass General Brigham Stroke Network Collaborative Department
- 2001–2002
Vascular Neurology
- 2000–2001
- 1995
University of Bombay
- 1994–1995
BYL Nair Hospital
Research
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
New England Journal of Medicine · 2021 · 780 citations
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
New England Journal of Medicine · 2021 · 743 citations
Narrative review: reversible cerebral vasoconstriction syndromes
Review · Annals of Internal Medicine · 2007 · Last of 4 authors · 627 citations
- WK
25 papers
24 papers
- HA
20 papers
- AS
18 papers
- LS
17 papers
- ML
17 papers
17 papers
13 papers · 7 as a resident
Grants
- 2018–2028
New England Regional Coordinating Center for the NINDS Stroke Trials Network (StrokeNet)
National Institute of Neurological Disorders and Stroke · U24
Contact PI · $1.9M · Massachusetts General Hospital
- 2011–2015
Indo-US Collaborative Stroke Registry and Infrastructure Development
National Institute of Neurological Disorders and Stroke · R21
Contact PI · $475.4K · Massachusetts General Hospital
- 2006–2013
Normobaric Hyperoxia in Acute Ischemic Stroke
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $2.1M · Massachusetts General Hospital
- 2006–2011
Specialized Programs of Translational Research in Acute Stroke at the Partners
National Institute of Neurological Disorders and Stroke · P50
Project lead · $1.1M · Massachusetts General Hospital
Clinical trials
- 2012–2015
Normobaric Oxygen (NBO) Therapy in Acute Migraine
Principal investigator · Completed · Phase 2
Massachusetts General Hospital
- 2007–2009
Normobaric Oxygen Therapy in Acute Ischemic Stroke Trial
Principal investigator · Terminated · Phase 2
Massachusetts General Hospital
- 2024–2027
Strategy for Improving Stroke Treatment Response
Site PI · Recruiting · Phase 2
Translational Sciences, Inc.